Kaili Deng

1.1k total citations · 1 hit paper
35 papers, 706 citations indexed

About

Kaili Deng is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kaili Deng has authored 35 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Kaili Deng's work include Liver Disease Diagnosis and Treatment (7 papers), Pharmacological Effects of Natural Compounds (4 papers) and Long-Term Effects of COVID-19 (4 papers). Kaili Deng is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Pharmacological Effects of Natural Compounds (4 papers) and Long-Term Effects of COVID-19 (4 papers). Kaili Deng collaborates with scholars based in China, Sweden and New Zealand. Kaili Deng's co-authors include Ganzhu Feng, Yuping Zhou, Lei Shu, Jing Yao, Xingran Du, Ziyan Shen, Jiaxin Yan, Lei Shi, Mingjing Wu and Xiaolin Chen and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Chemical Engineering Journal.

In The Last Decade

Kaili Deng

34 papers receiving 700 citations

Hit Papers

Microplastic-mediated new mechanism of liver damage: From... 2024 2026 2025 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Microplastic-mediated new mechanism of liver damage: From the perspective of the gut-liver axis
    2024 65 citations Kaili Deng, Yuping Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaili Deng China 13 163 146 141 132 113 35 706
Ganzhu Feng China 18 271 1.7× 148 1.0× 178 1.3× 142 1.1× 152 1.3× 42 932
Elena Costa Italy 17 362 2.2× 21 0.1× 32 0.2× 40 0.3× 66 0.6× 44 727
Asad Abbas Pakistan 13 54 0.3× 40 0.3× 15 0.1× 85 0.6× 68 0.6× 31 628
Yuexing Tu China 18 313 1.9× 11 0.1× 93 0.7× 34 0.3× 87 0.8× 48 802
Shaoyan Zhang China 19 160 1.0× 60 0.4× 114 0.8× 16 0.1× 26 0.2× 70 937
Paul B. Spalding United States 7 150 0.9× 68 0.5× 68 0.5× 9 0.1× 44 0.4× 11 545
Maral Mokhtari Iran 14 109 0.7× 35 0.2× 51 0.4× 33 0.3× 45 0.4× 109 650
Takeji Matsushita Japan 13 96 0.6× 20 0.1× 43 0.3× 24 0.2× 19 0.2× 48 563
Anno Saris Netherlands 15 101 0.6× 18 0.1× 240 1.7× 70 0.5× 14 0.1× 32 779
Renin Chang Taiwan 14 191 1.2× 10 0.1× 94 0.7× 76 0.6× 11 0.1× 82 723

Countries citing papers authored by Kaili Deng

Since Specialization
Citations

This map shows the geographic impact of Kaili Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaili Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaili Deng more than expected).

Fields of papers citing papers by Kaili Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaili Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaili Deng. The network helps show where Kaili Deng may publish in the future.

Co-authorship network of co-authors of Kaili Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Kaili Deng. A scholar is included among the top collaborators of Kaili Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaili Deng. Kaili Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Kaili, Min Li, Yuhua Wang, et al.. (2025). Integrated UHPLC-Q-exactive orbitrap HRMS and serum pharmacochemistry for the investigation of anti-hepatic fibrosis effect of Baoganning Decoction. Phytomedicine. 137. 156363–156363. 7 indexed citations
2.
Wang, Yuhua, Ké Li, Min Yang, et al.. (2025). Astragalin promotes HSCs ferroptosis through NCOA4 mediated ferritinophagy to alleviate liver fibrosis in zebrafish and mice. Communications Biology. 8(1). 1081–1081. 1 indexed citations
3.
Li, Yamei, Kaili Deng, Yuanyuan Li, et al.. (2025). Serum pharmacochemistry and network pharmacology reveal the effect and mechanism of licorice extracts on colorectal cancer. Phytomedicine. 145. 156860–156860. 2 indexed citations
4.
Huang, Sha, Yuhua Wang, Jin Fu Wen, et al.. (2025). Baicalin mitigates alcoholic-associated liver disease via SOCS1-driven reprogramming of macrophages. Chinese Medicine. 20(1). 63–63. 2 indexed citations
5.
6.
7.
Deng, Kaili, Hailong Tian, Edouard C. Nice, et al.. (2024). Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer. Journal of Controlled Release. 366. 684–693. 13 indexed citations
8.
Cao, Yang, Xiaolin Chen, Lei Shu, et al.. (2023). Analysis of the correlation between BMI and respiratory tract microbiota in acute exacerbation of COPD. Frontiers in Cellular and Infection Microbiology. 13. 1161203–1161203. 1 indexed citations
9.
Deng, Kaili, et al.. (2023). Function of macrophage-derived exosomes in chronic liver disease: From pathogenesis to treatment. World Journal of Hepatology. 15(11). 1196–1209. 2 indexed citations
10.
Zhou, Yuping, et al.. (2023). Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics. Journal of Pharmaceutical Analysis. 13(9). 1058–1069. 15 indexed citations
11.
12.
Shi, Lei, You Zheng, Zhi Cheng, et al.. (2022). One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment. Stem Cell Research & Therapy. 13(1). 321–321. 6 indexed citations
13.
14.
Deng, Kaili, et al.. (2022). Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy. Pharmaceutics. 14(7). 1344–1344. 23 indexed citations
15.
Feng, Ganzhu, Lei Shi, Tingrong Huang, et al.. (2021). Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge. Stem Cells and Development. 30(15). 773–781. 18 indexed citations
16.
Du, Xingran, Jianpeng Xue, Yuzhen Huang, et al.. (2021). A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against Acinetobacter baumannii Infection. International Journal of Nanomedicine. Volume 16. 1819–1836. 54 indexed citations
17.
Shu, Lei, Ruyou Li, Tingrong Huang, et al.. (2020). Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Research & Therapy. 11(1). 361–361. 211 indexed citations
18.
Shu, Lei, Mingquan Li, Xiaolin Chen, et al.. (2020). Clinical Characteristics of 545 Cases Confirmed COVID-19 in Wuhan Stadium Cabin Hospital. SSRN Electronic Journal. 6 indexed citations
19.
Du, Xingran, Xinfeng Xu, Jing Yao, et al.. (2019). Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis. American Journal of Infection Control. 47(9). 1140–1145. 96 indexed citations
20.
Deng, Kaili, Jin Cui, Yong Qin, Yina Zhu, & Ganzhu Feng. (2019). First report of sparganosis manifested by pleuritis and decreased peripheral blood eosinophils in Jiangsu province, China. Parasitology Research. 118(5). 1653–1656. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ganzhu Feng Breakdown of academic impact, for papers by Elena Costa Breakdown of academic impact, for papers by Asad Abbas Breakdown of academic impact, for papers by Yuexing Tu Breakdown of academic impact, for papers by Shaoyan Zhang Breakdown of academic impact, for papers by Paul B. Spalding Breakdown of academic impact, for papers by Maral Mokhtari Breakdown of academic impact, for papers by Takeji Matsushita Breakdown of academic impact, for papers by Anno Saris Breakdown of academic impact, for papers by Renin Chang
Rankless by CCL
2026